Accessing complexity: The dynamics of virus-specific T cell responses

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 561-592

  Doherty, Peter C ^a   Christensen, Jan P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cell mediated immunity; Inflammation; Memory; Pneumonia; Recall response; Tetramers

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TETRAMER; VIRUS ANTIGEN;

CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CYTOTOXIC T LYMPHOCYTE; DNA VIRUS; HERPES VIRUS; HUMAN; INFLAMMATION; INFLUENZA VIRUS; LATENT PERIOD; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOID TISSUE; MEMORY CELL; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RNA VIRUS; SENDAI VIRUS; VIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; VIRUSES;

EID: 0034130060     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.561     Document Type: Review

References (142)

1. Sprent J, Tough DF. 1994. Lymphocyte life-span and memory. Science 265:1395-400
2. + T cell pools. Eur. J. Immunol. 25:2127-36
3. + T cell memory. Immunol. Rev. 150:23-44
4. Doherty PC, Hamilton-Easton AM, Topham DJ, Riberdy J, Brooks JW, Cardin RD. 1997. Consequences of viral infections for lymphocyte compartmentalization and homeostasis. Semin. Immunol. 9:365-73
5. Tough DF, Sprent J. 1994. Turnover of naive-and memory-phenotype T cells. J. Exp. Med. 179:1127-35
6. + T cells. Proc. Natl. Acad. Sci. USA 96:8597-602
7. De Boer RJ, Perelson AS. 1997. Competitive control of the self-renewing T cell repertoire. Int. Immunol. 9:779-90
8. Antia R, Pilyugin SS, Ahmed R. 1998. Models of immune memory: on the role of cross-reactive stimulation, competition, and homeostasis in maintaining immune memory. Proc. Natl. Acad. Sci. USA 95:14926-31
9. Nowak MA, Bangham CR. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74-79
10. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96
11. + Tcells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc. Natl. Acad. Sci. USA 95:7568-73
12. Crawford F, Kozono H, White J, Marrack P, Kappler J. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675-82
13. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-87
14. + T cells in primary and secondary influenza pneumonia. Immunity 8:683-91
15. Kuroda MJ, Schmitz JE, Barouch DH, Craiu A, Allen TM, Sette A, Watkins DI, Forman MA, Letvin NL. 1998. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187:1373-81
16. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395-402
17. Belz GT, Altman JD, Doherty PC. 1998. Characteristics of virus-specific CD8( + ) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc. Natl. Acad. Sci. USA 95:13812-17
18. + T-cell memory is induced by Sendai virus infection of mice. J. Virol 73:7278-86
19. Walker JA, Sakaguchi T, Matsuda Y, Yoshida T, Kawaoka Y. 1992. Location and character of the cellular enzyme that cleaves the hemagglutinin of a virulent avian influenza virus. Virology 190:278-87
20. Tashiro M, Seto JT, Choosakul S, Hegemann H, Klenk HD, Rott R. 1992. Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice. J. Gen. Virol. 73:1575-79
21. Horimoto T, Kawaoka Y. 1995. The hemagglutinin cleavability of a virulent avian influenza virus by subtilisin-like endoproteases is influenced by the amino acid immediately downstream of the cleavage site. Virology 210:466-70
22. McWilliam AS, Napoli S, Marsh AM, Pemper FL, Nelson DJ, Pimm CL, Stumbles PA, Wells TNC, Holt PG. 1996. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184:2429-32
23. McWilliam AS, Marsh AM, Holt PG. 1997. Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: involvement of epithelial dendritic cells. J. Virol. 71:226-36
24. Hamilton-Easton AM, Eichelberger M. 1995. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J. Virol. 69:6359-66
25. Usherwood EJ, Hogg TL, Woodland DL. 1999. Enumeration of antigen-presenting cells in mice infected with Sendai virus. J. Immunol. 162:3350-55
26. Bujdoso R, Hopkins J, Dutia BM, Young P, McConnell I. 1989. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J. Exp. Med. 170:1285-301
27. Eichelberger MC, Wang M, Allan W, Webster RG, Doherty PC. 1991. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J. Gen. Virol. 72:1695-98
28. Kawaoka Y. 1991. Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: potential use as an animal model. J. Virol. 65:3891-94
29. Riberdy JM, Flynn KJ, Stech J, Webster RG, Altman JD, Doherty PC. 1999. Protection against a lethal avian influenza A virus in a mammalian system. J. Virol. 73:1453-59
30. Webster RG. 1997. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch. Virol. 142:105-13
31. Yewdell JW, Bennink JR. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1-123
32. Townsend AR, Gotch FM, Davey J. 1985. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457-67
33. Doherty PC, Effros RB, Bennink J. 1977. Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses. Proc. Natl. Acad. Sci. USA 74:1209-13
34. Effros RB, Bennink J, Doherty PC. 1978. Characteristics of secondary cytotoxic T-cell responses in mice infected with influenza A viruses. Cell Immunol. 36:345-53
35. Patick AK, Thiemann RL, O'Brien PC, Rodriguez N. 1991. Persistence of Theiler's virus infection following promotion of central nervous system remyelination. J. Neuropathol. Exp. Neural. 50:523-37
36. Gallagher TM, Buchmeier MJ, Perlman. 1992. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology 191:517-22
37. Ruttkay-Nedecka S, Rajcani J, Eleckova E, Ruttkay-Nedecky G. 1987. Infection of the central nervous system of mice by standard Sendai virus, defective interfering Sendai virus and the mixture of both: comparison of virus multiplication and pathogenicity. Acta Virol. 31:78-82
38. Cattaneo R, Schmid A, Rebmann G, Baczko K, Ter Meulen V, Bellini WJ, Rozenblatt S, Billeter MA. 1986. Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology 154:97-107
39. Dhib-Jalbut S, McFarland HF, Mingioli ES, Sever JL, McFarlin DE. 1988. Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis. J. Virol. 62:2483-89
40. Hotchin J. 1974. The role of transient infection in arenavirus persistence. Prog. Med. Virol. 18:81-93
41. Gilden DH, Cole GA, Nathanson N. 1972. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J. Exp. Med. 135:874-89
42. Marker O, Volkert M. 1973. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137:1511-25
43. Zinkernagel RM, Doherty PC. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:51-177
44. Moskophidis D, Assmann-Wischer U, Simon MM, Lehmann-Brube F. 1987. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Eur. J. Immunol. 17:937-42
45. Ahmed R, Gary D. 1996. Immunological memory and protective immunity: Understanding their relation. Science 272:54-60
46. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MB. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275-331
47. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648-52
48. Klenerman P, Hengartner H, Zinkernagel RM. 1997. A non-retroviral RNA virus persists in DNA form. Nature 390:298-301
49. Kägi D, Seiler P, Pavlovic J, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. 1995. The roles of perforin-and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256-62
50. Suzuki S, Hotchin J. 1971. Initiation of persistent lymphocytic choriomeningitis infection in adult mice. J. Infect. Dis. 123:603-10
51. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-61
52. Brodie SJ, Lewinsohn DA, Patterson BK, Jiyamapa D, Krieger J, Corey L, Greenberg PD, Riddell SR. 1999. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5:34-41
53. Tan R, Xu X, Ogg GS, Hansasuta P, Dong T, Rostron T, Luzzi G, Conlon CP, Screaton GR, McMichael AJ, Rowland-Jones S. 1999. Rapid death of adoptively transferred T cells in acquired immuno-deficiency syndrome. Blood 93:1506-10
54. Hay CM, Ruhl DJ, Basgoz NO, Wilson CC, Billingsley JM, DePasquale MP, D'Aquila RT, Wolinsky SM, Crawford JM, Montefiori DC, Walker BD. 1999. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. J. Virol. 73:5509-19
55. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-60
56. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-86
57. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-6
58. Ogg GS, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Hurley A, Markowitz M, Ho DD, McMichael AJ, Nixon DF. 1999. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73:797-800
59. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce, M Oggs GS, Welsh KI, Weber JN, Lloyd LA, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 96:3848-53
60. Wodarz D, Nowak MA, Bangham CR. 1999. The dynamics of HTLV-I and the CTL response. Immunol. Today 20:220-27
61. Bieganowska K, Hollsberg P, Buckle GJ, Lim DG, Greten TF, Schneck J, Altman JD, Jacobson S, Ledis SL, Hanchard B, Chin J, Morgan O, Roth PA, Hafler DA. 1999. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/ Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J. Immunol. 162:1765-71
62. Klein G. 1994. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77 7:791-93
63. Nash AA, Sunil-Chandra NP. 1994. Interactions of the murine gammaherpes-virus with the immune system. Curr. Opin. Immunol. 6:560-63
64. Rickinson AB, Moss DJ. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-31
65. Spriggs MK. 1996. One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 14:101-30
66. Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ, Spriggs MK. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-21
67. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Weck KE, Dal CA, Speck SH. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-904
68. Ganem D. 1998. Human herpesirus 8 and its role in the genesis of Kaposi's sarcoma. Curr. Clin. Top. Infect. Dis. 18:327-51
69. Orenstein JM, Alkan S, Blauvelt A, Jeang KT, Weinstein MD, Ganem D, Herndier B. 1997. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11:F35-45
70. Osman M, Kubo T, Gill J, Neipel F, Backer M, Smith G, Weiss R, Gazzard B, Boshoff C, Gotch F. 1999. Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J. Virol. 73:6136-40
71. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson Kieff E, Cohen JI. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-85
72. Sunil-Chandra NP, Efstathiou S, Nash AA. 1993. Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology 193:825-33
73. Walling DM, Raab-Traub N. 1994. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J. Virol. 68:7909-17
74. + T cells. J. Exp. Med. 184:863-71
75. + T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95:15565-70
76. Doherty PC, Tripp RA, Hamilton-Easton AM, Cardin RD, Woodland DL, Blackman MA. 1997. Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr. Opin. Immunol. 9:477-83
77. Henle G, Henle W, Diehl V. 1968. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 59:94-101
78. Tripp RA, Hamilton-Easton AM, Cardin RD, Nguyen P, Behm FG, Woodland DL, Doherty PC, Blackman MA. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J. Exp. Med. 185:1641-50
79. + peripheral blood T lymphocytes. Submitted for publication
80. Stevenson PG, Belz GT, Altman JD, Doherty PC. 1999. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur. J. Immunol. 29:1059-67
81. + T cells and B cells in an infectious mononucleosis-like syndrome. J. Virol. 73:9650-54
82. + T cell activation associated with latent murine gammaherpesvirus infection. J. Immunol. 163:3403-8
83. + T cells in vivo during latent murine gammaherpesvirus infection. J. Immunol. 163:1481-89
84. Miller JFAP. 1999. Discovering the origins of immunological competence. Annu. Rev. Immunol. 17:1-17
85. Tanchot C, Lemonnier FA, Pérarnau B, Freitas AA, Rocha B. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057-62
86. Ford WL, Burr W, Simonsen M. 1970. A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells. Transplantation 10:258-66
87. Mackaness GB, Blanden RV. 1967. Cellular immunity. Prog. Allergy 11:89-40
88. Blanden RV. 1974. T cell response to viral and bacterial infection. Transplant. Rev. 19:56-88
89. Doherty PC, Zinkernagel RM. 1974. T-cell-mediated immunopathology in viral infections. Transplant. Rev. 19:89-120
90. Burnet FM, Burnet D. 1960. Graft versus host reactions on the chorioallantoic membrane of the chick embryo. Nature 188:376-79
91. Sexton C. 1991. The Seeds of Time: The Life of Sir Macfarlane Burnet. Melbourne: Oxford Univ. Press
92. Doherty PC. 1999. Burnet Oration: living in the Burnet lineage. Immunol. Cell Biol. 77:167-76
93. Burnet FM. 1967. The impact of ideas on immunology. Cold Spring Harbor Symp. Quant. Biol. 32:1-8
94. Talmage DW. 1957. Allergy and immunology. Annu. Rev. Med. 8:239-56
95. Cerottini JC, Brunner KT. 1974. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv. Immunol. 18:67-132
96. Zinkernagel RM, Doherty PC. 1997. The discovery of MHC restriction. Immunol. Today 18:14-17
97. Doherty PC, Zinkernagel RM. 1975. A biological role for the major histocompatibility antigens. Lancet 1:1406-9
98. 51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In Vitro Methods Cell-Mediated Tumor Immun. 1:423-28
99. Ryser JE, Sordat B, Cerottini JC, Brunner KT. 1977. Mechanism of target cell lysis of cytolytic T lymphocytes. I. Characterization of specific lymphocyte-target cell conjugates separated by velocity sedimentation. Eur. J. Immunol. 7:110-17
100. Schick B, Berke G. 1979. Competitive inhibition of cytotoxic T lymphocyte-target cell conjugation. A direct evaluation of membrane antigens involved in cell-mediated immunity. Transplantation 27:365-68
101. Owen JA, Allouche M, Doherty PC. 1982. Limiting dilution analysis of the specificity of influenza-immune cytotoxic T cells. Cell Immunol. 67:49-59
102. Maier B, Buhring HJ, Simon M, Eichmann K, Melchers I. 1986. Limiting dilution analysis of proliferating and helper T cells in the in vivo immune response to KLH: depression of helper T cells at moderately increased frequencies. J. Mol. Cell Immunol. 2:293-305
103. Tabi Z, Lynch F, Ceredig R, Allan JE, Doherty PC. 1988. Virus-specific memory T cells are Pgp-1 + and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol. 113:268-77
104. + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J. Immunol. 150:5494-500
105. + memory T cells. J Immunol. 154:5870-75
106. Doherty PC, Korngold R. 1983. Characteristics of poxvirus-induced meningitis: virus-specific and non-specific cytotoxic effectors in the inflammatory exudate. Scand. J. Immunol. 18:1-7
107. + T cells in respiratory virus infections. J. Immunol. 154:6013-21
108. McMichael AJ, O'Callaghan CA. 1998. A new look at T cells. J. Exp. Med. 187:1367-71
109. Miller RA, Reiss CS. 1984. Limiting dilution cultures reveal latent influenza virus-specific helper T cells in virus-primed mice. J. Mol. Cell. Immunol. 1:357-68
110. + T cells. Virology 210:179-85
111. + T cell response and memory. J. Immunol. 161:4530-35
112. Whitmire JK, Asano MS, Murali-Krishna K, Suresh M, Ahmed R. 1998. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72:8281-88
113. + T cell response to a persistent gammaherpesvirus. J. Virol. 73:4279-83
114. + T cells during an acute virus infection. Immunity 8:167-75
115. Niemialtowski MG, Rouse BT. 1992. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149:3035-39
116. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188:1047-54
117. + T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ. Proc. Natl. Acad. Sci. USA 96:5135-40
118. Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MF. 1999. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827-35
119. Stevenson PG, Belz GT, Altman JD, Doherty PC. 1999. Changing patterns of dominance in the CD8 + T cell response during acute and persistent murine gamma-herpesvirus infection. Eur. J. Immunol. 29:1059-67
120. Sourdive DJ, Murali-Krishna K, Altman JD, Zajac AJ, Whitmire JK, Pannetier C, Kourilsky P, Evavold B, Sette A, Ahmed R. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71-82
121. Jacob, J, Baltimore D. 1999. Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399:593-97
122. Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. 1999. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162:2227-34
123. + T cells during viral persistence in the CNS. J. Immunol. 163:3379-87
124. Johnson AJ, Njenga MK, Kuhns ST, Chen L, Rodriguez M, Pease LR. 1999. Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 73:3702-8
125. + T lymphocytes in semen of chronically infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Virol. 73:4508-12
126. + T cells in an in vivo response. J. Immunol. 155:3719-21
127. Tough DF, Borrow P, Sprent J. 1996. Induction of bystander T cell prolifration by viruses and type I interferon in vivo. Science 272:1947-50
128. + T cells in vivo by IL-15. Immunity 8:591-99
129. Nahill SR, Welsh RM. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177:317-27
130. Zarozinski CC, Welsh RM. 1997. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J. Exp. Med. 185:1629-39
131. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95:3810-15
132. Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lord CI, Forman MA, Letvin NL. 1999. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. J. Virol. 73:1573-79
133. Cole GA, Hogg TL, Woodland DL. 1994. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767-75
134. + T-cell memory determined by clonal burst size. Nature 369:652-54
135. + T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162:1780-88
136. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-13
137. Andrew ME, Coupar BE, Boyle DB, Ada GL. 1987. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand. J. Immunol. 25: 21-28
138. Doherty PC, Allan W, Boyle DB, Coupar BE, Andrew ME. 1989. Recombinant vaccinia viruses and the development of immunization strategies using influenza virus. J. Infect Dis. 159:1119-22
139. + T cell response primed to a lytic-phase epitope. Proc. Natl. Acad. Sci. USA 96:9281-86
140. + T cell memory in the absence of B cells and Ig. J. Immunol. 157:2947-52
141. Butcher EC Picker LJ. 1996. Lymphocyte homing and homeostasis. Science 272:60-66
142. Busch DH, Pilip IM, Vijh S, Pamer EG. 1998. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 8:353-62